Live Love Spa Launches Wellness Ambassador Program

It’s no secret that everyone in the spa and wellness industry has been hit hard by the shutdowns sanctioned due to the COVID-19 pandemic. In order to help spa professionals bring in some extra income and stimulate retail sales, the spa industry B-to-B company Live Love Spa and its supporting brand partners have developed a new Wellness Ambassador Program to help both businesses and individuals alike.

Professionals can apply to become an ambassador using an online form. Once approved, the applicant will receive a unique link they can use to make product recommendations of any of the brand partners at ShopLiveLoveSpa.com through methods including texts, blog posts, social media posts, and direct emails to clients. When someone uses the unique link to purchase the product, the professional will receive a 20 percent commission paid to them via PayPal every Friday. There is also a Personalized Wellness Ambassador portal to track sales, commissions, and payouts.

“The minute the COVID-19 shutdown happened, supporting brand partners and our team started to brainstorm how what we do could help,” says Lisa Michaelis, founder of Live Love Spa. “We’re thrilled and proud to do be able to offer a hand to our wonderful industry colleagues at a time like this.”

 

Additionally, program ambassadors do not need to own or ship their own inventory, and purchases include 24-hour order processing, free shipping, and gift-with-purchase opportunities. Items available on the website include skincare, bath and body products, candles, jewelry, towels, nail products, haircare, and at-home fitness products. Circadia, Epicuren, Sothys, Comfort Zone, Jurlique, Farmhouse Fresh, SpaRitual, Pure Fiji, Vita Liberata, Foreo, and Priori are just a few of the many professional wellness brands supporting the program.

 

RELATED STORIES

Infinity Sun Develops Product to Help Spray Tan Salons and Spas

How to Combat a COVID-19 Cash Flow Crisis

How One Big Name Spa is Supporting Franchisees During COVID-19